FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev...

CAMBRIDGE, Mass.--(BUSINESS WIRE) October 29, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company,...

With over 27,000 women in the Philippines diagnosed with breast cancer in 2021 alone, the need for early detection and treatment has never been more...

SCOTTSDALE, Ariz., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage...

From a casual observer to a cancer warrior, Diane Coetzer shares her insights on the physical and emotional challenges of the disease.

Using a gene signature technique to tailor chemotherapy for patients with early triple-negative breast cancer shows promise as a way to improve...

East Hanover, October 29, 2024 – Novartis announced today that Scemblix (asciminib) was granted accelerated approval by the US Food and Drug...

CARLSBAD, Calif., Nov. 4, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration...

The Vietnam Women’s Union (VWU) and Novartis Vietnam announced their partnership in the programme 'Raising awareness and enhancing support for women...

On October 29, 2024, the Food and Drug Administration granted accelerated approval to asciminib (Scemblix, Novartis AG) for adult patients with newly...